# Correction: Immune-related adverse events associated with nab-paclitaxel/paclitaxel combined with immune checkpoint inhibitors: a systematic review and network meta-analysis

**Authors:** Wenjing Hao, Jun Zhang, Yunxia Wang, Boyu Fang, Shasha Jin, Jing Yuan, Weimin Cai

PMC · DOI: 10.3389/fimmu.2026.1812769 · Frontiers in Immunology · 2026-03-05

## Full-text entities

- **Chemicals:** paclitaxel (MESH:D017239)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13000430/full.md

---
Source: https://tomesphere.com/paper/PMC13000430